SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 20.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $632,000 | -65.7% | 65,000 | -48.0% | 0.12% | -61.7% |
| Q3 2017 | $1,840,000 | -6.0% | 125,000 | +2.8% | 0.32% | -7.2% |
| Q2 2017 | $1,957,000 | +29.3% | 121,624 | +27.9% | 0.35% | +143.7% |
| Q1 2017 | $1,514,000 | +161.9% | 95,100 | +100.0% | 0.14% | +25.7% |
| Q4 2016 | $578,000 | -12.4% | 47,550 | 0.0% | 0.11% | -6.6% |
| Q3 2016 | $660,000 | – | 47,550 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|